abs412.txt	purpose		infused	autologous	tumor-infiltrating	lymphocytes	(til)	andtumor-targeted	chimeric	antigen	receptor	(car)	t	cells	typically	surroundmalignant	lesions	or	penetrate	small	tumor	nodules	but	fail	to	penetrate	largesolid	tumors		significantly	compromising	their	antitumor	impact		strategies	toovercome	this	primary	challenge	are	largely	required	experimental	design		wetested	the	effects	of	il12	plus	doxorubicin	on	t-cell	penetration	and	efficacy	insolid	tumors	in	a	murine	lung	cancer	model		a	murine	breast	carcinoma	lungmetastasis	model		and	two	human	xenograft	tumor	models	bearing	large	tumors	(>10mm)	results		intriguingly		this	simple	approach	increased	the	numbers		thedistribution		and	the	depth	of	penetration	of	infused	cd8+	t	cells	in	thesetumors		including	both	tils	and	car	t	cells		this	combined	treatment	halted	tumorprogression	and	significantly	extended	survival	time		studies	of	the	underlyingmechanism	revealed	multiple	effects		first		the	combined	treatment	maintained	thehigh	ratios	of	immune-stimulatory	receptors	to	immune-inhibitory	receptors	oninfiltrated	cd8+	t	cells		reduced	the	accumulation	of	immunosuppressiveregulatory	t	cells		and	enhanced	the	numbers	of	t-bet+	effector	t	cells	in	thetumors		second		doxorubicin	induced	chemokines	cxcl9	and	cxcl10		which	mayattract	nkg2d+cd8+	t	cells	to	tumors		and	this	effect	was	boosted	by	il12-inducedifnγ	accumulation	in	tumors		promoting	the	penetration	of	nkg2d+cd8+	tcells	conclusions		the	deep	penetration	of	infused	t	cells	associated	withcombined	il12	plus	doxorubicin	yielded	striking	therapeutic	effects	in	murine	andhuman	xenograft	solid	tumors		this	approach	might	broaden	the	application	oft-cell	therapy	to	a	wider	range	of	solid	tumors		clin	cancer	res		24(12)	2920-34		©2018	aacrsee	related	commentary	by	berraondo	et	al			p		2716	
